Stamps v. Collagen Corp
Stamps v. Collagen Corp, 510 U.S. 824 (1993)
Opinion
Stamps v. Collagen Corp.
No. 92-1989.
Supreme Court of United States.
October 4, 1993.
1
Appeal from the C. A. 5th Cir.
2
Certiorari denied. Reported below: 984 F. 2d 1416 .
How later courts describe this case
Explanatory parentheticals written by citing courts — 13 in all; the most informative distinct ones are shown.
-
(holding that existence of express preemption clause precludes reliance on implied preemption doctrine, without determining whether provision constituted a "reliable indicium of congressional intent")
-
(holding that the analysis used in Ferebee did not survive the Cipollone decision)
-
(finding that the express preemption provision in the MDA precludes any discussion regarding implied preemption)
-
(holding state law claims not preempted where FDA had established no specific requirements unique to the Class III medical device at issue)
-
(finding that the PMA process constitutes a “specific requirement” applicable to a particular device)
-
(“[W]e do not believe the [preemption] analysis [in Fere- bee] can be said to have survived Cipol- lone-”)
-
(claims of failure to warn and defective design preempted where manufacturer of Class III device underwent PMA)
-
(relying on Cipollone for interpretation of state “requirement” under MDA)
Cited by 83 cases
View all citing references →Relies on it most ⓘ
Citing references are not a citator: they show that a later opinion cites this case, not whether it followed, distinguished, or overruled it. Check negative history before relying on this case.